Method for targeting chemical compounds to cells and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 49/00 (2006.01) A61K 31/198 (2006.01)

Patent

CA 2441111

The present invention concerns a method for selectively targeting a medicinally-useful agent into cells in which a phospholipid scramblase (PLS) transport system is activated. The method comprises administering the agent, being a PLS-dependent transported compound (PDTC) to the cells, thereby causing selective transport of the agent into the cells. Examples of the cells are apoptotic cells, activated cells and injured cells. Also disclosed are pharmaceutical compositions for use by the method.

La présente invention porte sur un procédé de ciblage sélectif d'un agent utile en médecine sur des cellules dans lesquelles un système de transport scramblase phospholipidique (PLS) est activé. Le procédé consiste à administrer l'agent, qui est un composé transporté dépendant de PLS (PDTC) dans les cellules, ce qui génère le transport sélectif de l'agent dans les cellules. Ces cellules sont par exemple des cellules apoptiques, des cellules activées et des cellules lésées. L'invention porte également sur des compositions pharmaceutiques destinées à être utilisées par ce procédé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for targeting chemical compounds to cells and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for targeting chemical compounds to cells and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for targeting chemical compounds to cells and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1805660

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.